ClinicalTrials.gg
Enrolling by invitationNCT07659015PICUpdated Aug 13, 2026

Use of Hand Extension Rubber During Intravenous Catheter Placement

An interventional study of Hand Extension Rubber in Pain, Anxiety and Satisfaction, sponsored by Necmettin Erbakan University. Enrolling by invitation at 1 site in Turkey (Türkiye). Open to participants aged 18 Years to 65 Years. Per ClinicalTrials.gov, last updated 2026-08-13.

Sponsored by Necmettin Erbakan University · Not applicable, Interventional, and Basic science

Phase
Not applicable
Study type
Interventional
Enrollment
114
Allocation
Randomized
Ages
18 Years to 65 Years
Sex
All
01

Study summary

The study aims to investigate the effect of a hand extension rubber used in patients with peripheral intravenous catheters on pain, anxiety, and satisfaction.

Read the detailed description

While the use of non-pharmacological methods to reduce pain and anxiety levels and increase satisfaction during peripheral intravenous catheterization has gained importance in recent years, studies on techniques that are easy to implement, low-cost, and proven to be effective-particularly in adults-remain limited. It is believed that the hand extension rubber has the potential to reduce pain and anxiety as a distraction method, thereby increasing patient satisfaction. The findings will enhance nurses' adherence to evidence-based practices and improve the quality of patient care. This study holds unique value as it is the first research in Turkey to address this method in adult individuals.

02

Conditions studied

  • Pain
  • Anxiety
  • Satisfaction

Keywords

  • Nursing
  • Peripheral intravenous catheter
  • PIC
  • Pain
  • Anxiety
  • Satisfaction
03

In context

Pain

10,054 studies on the registry are indexed under Pain; 1,649 are open to participants now.

This study's planned enrollment of 114 is above the median of 66 across 8,493 interventional studies indexed under Pain.

Browse Pain studies →

Lead sponsor

Necmettin Erbakan University is the lead sponsor of 201 studies on the registry; 48 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 65 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Volunteers willing to participate in the study
  • Patients aged 18-65
  • Patients who are alert and able to communicate verbally in Turkish
  • Patients assigned to the green zone during triage
  • Patients suitable for PICC placement in the left cephalic and basilic veins
  • Patients who are right-handed
  • Patients with a VAS pain score of 0 prior to the PIC procedure

Exclusion criteria

Exclusion Criteria:

  • Patients with acute or chronic pain
  • Patients with conditions that cause limited mobility, such as muscle disorders or grip dysfunction
  • Patients with peripheral neuropathy, arteriovenous fistula, or bilateral mastectomy
  • Patients with a psychiatric diagnosis (as self-reported)
  • Patients with communication impairments (hearing, speech, and vision)
  • Patients with a history of negative PIC procedure experiences

Terminating Criteria:

  • Participants wishing to withdraw from the study at any stage after giving their consent
  • Failure of the PIC procedure
  • Failure to use the hand extension band until the end of the procedure
  • Occurrence of complications related to the PIC procedure during the procedure
05

Study design

Phase
Not applicable
Primary purpose
Basic science
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
114 participants (estimated)

Study arms

  • Experimental
    İntervention

    Hand Extension Rubber will be used for distraction

    Other: Hand Extension Rubber

  • No intervention
    control

    No intervention group

Interventions

  • OtherHand Extension Rubber

    Hand Extension Rubber will be used for distraction while peripheral IV catheher placement.

06

What researchers measure

Primary outcomes

  1. Pain associated with PIC procedure (using VAS-visual analogue scale)

    Pain associated with PIC procedure

    Time frame: after the PIC implementation

Secondary outcomes

  1. satisfaction associated with PIC procedure (using State-Trait Anxiety Inventory)

    satisfaction

    Time frame: after the PIC implementation

  2. anxiety associated with PIC procedure (using a five likert type quesiton-)

    anxiety

    Time frame: after the PIC implementation

07

Study locations

1 site
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Aug 13, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT07659015
Collaborators
Konya Necmettin Erbakan Üniversitesi
Responsible party
Gulden Basit (Associate Professor, Ph.D., Necmettin Erbakan University) — Principal investigator
First posted
Jun 22, 2026
Start date
Aug 12, 2026
Primary completion
Oct 1, 2026 (estimated)
Completion
Oct 1, 2026 (estimated)
Last update
Aug 13, 2026

Study contacts

Melike Kışla
principal investigator · Master student

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

No contact was published for this record. The registry link below has the sponsor’s details.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion